This information was originally presented on September 21, 2013, at the NCCN 8^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This live 75-minute webcast, with interactive Q&A and patient-physician video case studies, is designed to meet the educational needs of physicians, nurses, pharmacists, and other health care professionals who manage patients with cancer.

This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

Vaccination is an important strategy for preventing infections in patients with hematologic malignancies. Hematopoietic cell transplant (HCT) recipients have diminished immunity against vaccine-preventable diseases after transplantation.